Nomura Holdings
ALXN

Nomura Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Nomura Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-300,000
Closed -$35.9M – 1757
2017
Q4 		$35.9M Buy
300,000
+269,200
+874% +$32.8M 0.06% 181
2017
Q3 		$4.32M Sell
30,800
-97,100
-76% -$13.2M 0.01% 590
2017
Q2 		$15.6M Buy
+127,900
New +$14.9M 0.04% 247
2016
Q3 		– Sell
-132,800
Closed -$15.7M – 1444
2016
Q2 		$15.7M Buy
+132,800
New +$18.8M 0.05% 205

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Nomura Holdings's ALXN Position: Q3 2021 in Review

Nomura Holdings sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 38,092 shares — an estimated $7M sold.

Nomura Holdings first reported a position in ALXN in Q2 2013 and held it in 31 quarters. The position peaked at $76.5M in Q3 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Nomura Holdings reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Nomura Holdings sold 38,092 Alexion Pharmaceuticals shares in Q3 2021, an estimated $7M.
  • Nomura Holdings first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 31 quarters.
  • Nomura Holdings's Alexion Pharmaceuticals position peaked at $76.5M in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Nomura Holdings's 13F filing for Q3 2021, filed 15 Nov 2021.